FINWIRES · TerminalLIVE
FINWIRES

中東和平への期待感から、米国株式先物は取引開始前に小幅上昇した。

-- 木曜日の米国株式先物は、中東紛争終結への期待が高まり、第2回協議と停戦延長の可能性が浮上したことを受け、取引開始前に上昇した。 ダウ工業株30種平均先物は0.1%高、S&P500先物は0.1%高、ナスダック先物は0.2%安となった。 イスラエルの安全保障内閣は水曜日に会合を開き、レバノンでの停戦の可能性について協議した。これは、より広範な和平合意に向けた主要な障害を取り除く可能性がある。 今週に入ってからの一連の堅調な決算発表も、経済への懸念を和らげている。台湾積体電路製造(TSMC)とチャールズ・シュワブ(SCHW)は第1四半期の利益と純収益がともに増加した。ネットフリックス(NFLX)は市場取引終了後に決算発表を予定している。 原油価格は上昇し、北海ブレント原油の期近先物は0.7%高の1バレル95.60ドル、米国産WTI原油は1バレル91.28ドルで横ばいとなった。 ブルームバーグがまとめた推計によると、4月11日までの週の新規失業保険申請件数は21万3000件となり、前週の21万9000件から減少したとみられる。 午前9時15分(米国東部時間)に発表される3月の鉱工業生産指数は、前月の0.2%増に続き、0.1%増になると予想されている。

Related Articles

Asia

Clinuvel Unlikely to Seek Scenesse's Vitiligo Approval Before Phase 3 Completion, Says Jefferies

Clinuvel Pharmaceuticals (ASX:CUV) is unlikely to seek regulatory approval for Scenesse in vitiligo until the Phase 3 CUV105 and CUV107 clinical trials are completed, according to a Friday Jefferies note.The company said on Friday that the European Medicines Agency (EMA) has proposed evaluating the company's Scenesse drug for the treatment of systemic vitiligo based on a "totality of evidence" regulatory approach.Jefferies said that the EMA's decision is a positive for the company because of the high unmet medical need for Vitiligo treatment.The investment firm has pushed back its revenue expectations from Scenesse in vitiligo, which is now expected to begin in the second half of fiscal 2029 rather than fiscal 2028.Jefferies kept a buy rating on Clinuvel and cut its price target to AU$39.20 from AU$40.50.

$ASX:CUV
Asia

ASX Preview: Australian Shares Set to Open Flat on Stalled US-Iran Talks; Origin Energy Reports Lower March Quarter Production

Australian shares are set to open flat on Monday, as oil prices climbed almost 2% following stalled US-Iran peace negotiations and restricted flows through the Strait of Hormuz, tightening global supply and pushing Brent crude above $107 a barrel.On April 25, the S&P 500 and the Nasdaq Composite rose 0.8% and 1.6%, respectively, while the Dow Jones Industrial Average fell 0.2%.In the macroeconomy, investors are eyeing the release of Australia's consumer price index report on Wednesday.In corporate news, Origin Energy (ASX:ORG) reported March quarter production of 164.5 petajoules, down from 167.1 petajoules a year earlier, according to a Monday filing with the Australian bourse.IperionX's (ASX:IPX) titanium powder production operations in Virginia, US, transitioned to an around-the-clock production schedule during the March quarter, advancing from commissioning to continuous operations, according to a Monday filing with the Australian bourse.Australia's benchmark index fell 0.1% or 6.9 points to close at 8,786.50 on April 24.

$^AXJO$ASX:IPX$ASX:ORG
Asia

Cobre Appoints Chief Financial Officer

Cobre (ASX:CBE) has appointed Kaveen Bachoo as chief financial officer, effective April 28, according to a Monday filing with the Australian bourse.Bachoo has over 20 years of finance leadership experience in the mining sector, including executive positions at Glencore.

$ASX:CBE